Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Alshukairi, Abeer N. ; Zhao, Jincun ; Al-Mozaini, Maha A. ; Wang, Yanqun ; Dada, Ashraf ; Baharoon, Salim A. ; Alfaraj, Sara ; Ahmed, Waleed A. ; Enani, Mushira A. ; Elzein, Fatehi E. ; Eltayeb, Nazik ; Layqah, Laila ; El-Saed, Aiman ; Bahaudden, Husam A. ; Haseeb, Abdul ; El-Kafrawy, Sherif A. ; Hassan, Ahmed M. ; Siddiq, Najlaa A. ; Alsharif, Ibtihaj ; Qushmaq, Isamel ; Azhar, Esam I. ; Perlman, Stanley ; Memish, Ziad A.
• Description:
  Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
• Subjects:
  Antibody Responses Coronaviruses Disease Severity Dispatch Humans Longevity Longevity Of Middle East Respiratory Syndrome Coronavirus Antibody Responses In Humans, Saudi Arabia Mers Mers-Cov Middle East Respiratory Syndrome Middle East Respiratory Syndrome Coronavirus Patients Viruses Zoonoses

  More +
• Source:
  Emerg Infect Dis. 27(5):1472-1476
• Pubmed ID:
  33900908
• Pubmed Central ID:
  PMC8084512
• Document Type:
  Journal Article
• Funding:
  P01 AI060699/AI/NIAID NIH HHS/United States
• Place as Subject:
  Saudi Arabia
• Volume:
  27
• Issue:
  5
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:9c73a81e5fb6fbbf460bb96f28fa56a3186927bddcb3860d305853284bfabafd
• Download URL:
  https://stacks.cdc.gov/view/cdc/106014/cdc_106014_DS1.pdf
• File Type:
  [PDF - 1018.73 KB ]